vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and HARVARD BIOSCIENCE INC (HBIO). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $23.7M, roughly 1.3× HARVARD BIOSCIENCE INC). HARVARD BIOSCIENCE INC runs the higher net margin — -12.0% vs -438.1%, a 426.1% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs -3.3%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs -1.6%).
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO.
DOMH vs HBIO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $23.7M |
| Net Profit | $-131.8M | $-2.8M |
| Gross Margin | — | 59.7% |
| Operating Margin | -8.9% | 7.2% |
| Net Margin | -438.1% | -12.0% |
| Revenue YoY | 220.4% | -3.3% |
| Net Profit YoY | -12426.2% | -15916.7% |
| EPS (diluted) | $-6.94 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | $23.7M | ||
| Q3 25 | $50.8M | $20.6M | ||
| Q2 25 | $34.1M | $20.4M | ||
| Q1 25 | $8.1M | $21.8M | ||
| Q4 24 | $9.4M | $24.6M | ||
| Q3 24 | $4.0M | $22.0M | ||
| Q2 24 | $6.2M | $23.1M | ||
| Q1 24 | $1.4M | $24.5M |
| Q4 25 | $-131.8M | $-2.8M | ||
| Q3 25 | $125.2M | $-1.2M | ||
| Q2 25 | $16.6M | $-2.3M | ||
| Q1 25 | $-32.5M | $-50.3M | ||
| Q4 24 | $1.1M | $18.0K | ||
| Q3 24 | $-4.2M | $-4.8M | ||
| Q2 24 | $-6.1M | $-2.9M | ||
| Q1 24 | $-5.4M | $-4.7M |
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 58.4% | ||
| Q2 25 | — | 56.4% | ||
| Q1 25 | — | 56.0% | ||
| Q4 24 | — | 57.1% | ||
| Q3 24 | — | 58.1% | ||
| Q2 24 | — | 57.2% | ||
| Q1 24 | — | 60.3% |
| Q4 25 | -8.9% | 7.2% | ||
| Q3 25 | -3.1% | 1.0% | ||
| Q2 25 | -57.0% | -4.0% | ||
| Q1 25 | -394.6% | -228.1% | ||
| Q4 24 | 0.4% | 0.0% | ||
| Q3 24 | -79.1% | -8.5% | ||
| Q2 24 | -44.3% | -9.0% | ||
| Q1 24 | -205.2% | -9.3% |
| Q4 25 | -438.1% | -12.0% | ||
| Q3 25 | 246.4% | -6.0% | ||
| Q2 25 | 48.7% | -11.2% | ||
| Q1 25 | -400.5% | -231.2% | ||
| Q4 24 | 11.4% | 0.1% | ||
| Q3 24 | -104.2% | -21.9% | ||
| Q2 24 | -99.1% | -12.7% | ||
| Q1 24 | -398.0% | -19.1% |
| Q4 25 | $-6.94 | $-0.06 | ||
| Q3 25 | $7.27 | $-0.03 | ||
| Q2 25 | $1.12 | $-0.05 | ||
| Q1 25 | $-3.02 | $-1.14 | ||
| Q4 24 | $0.21 | $0.01 | ||
| Q3 24 | $-0.67 | $-0.11 | ||
| Q2 24 | $-1.01 | $-0.07 | ||
| Q1 24 | $-0.91 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $8.6M |
| Total DebtLower is stronger | — | $35.9M |
| Stockholders' EquityBook value | $69.4M | $13.7M |
| Total Assets | $112.9M | $80.1M |
| Debt / EquityLower = less leverage | — | 2.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | $8.6M | ||
| Q3 25 | $176.2M | $6.8M | ||
| Q2 25 | $28.2M | $7.4M | ||
| Q1 25 | $18.9M | $5.5M | ||
| Q4 24 | $8.2M | $4.1M | ||
| Q3 24 | $7.2M | $4.6M | ||
| Q2 24 | $12.1M | $4.0M | ||
| Q1 24 | $7.1M | $4.3M |
| Q4 25 | — | $35.9M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $34.9M | ||
| Q1 25 | — | $36.4M | ||
| Q4 24 | — | $37.0M | ||
| Q3 24 | — | $34.9M | ||
| Q2 24 | — | $35.7M | ||
| Q1 24 | — | $35.6M |
| Q4 25 | $69.4M | $13.7M | ||
| Q3 25 | $210.2M | $14.1M | ||
| Q2 25 | $88.6M | $15.7M | ||
| Q1 25 | $42.4M | $14.8M | ||
| Q4 24 | $39.9M | $63.3M | ||
| Q3 24 | $38.3M | $65.3M | ||
| Q2 24 | $42.4M | $67.2M | ||
| Q1 24 | $47.7M | $68.8M |
| Q4 25 | $112.9M | $80.1M | ||
| Q3 25 | $223.4M | $78.0M | ||
| Q2 25 | $109.3M | $80.1M | ||
| Q1 25 | $52.3M | $79.8M | ||
| Q4 24 | $47.1M | $126.6M | ||
| Q3 24 | $43.4M | $131.2M | ||
| Q2 24 | $49.1M | $128.9M | ||
| Q1 24 | $52.2M | $133.2M |
| Q4 25 | — | 2.61× | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | 2.45× | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.52× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $-96.0K |
| Free Cash FlowOCF − Capex | — | $-545.0K |
| FCF MarginFCF / Revenue | — | -2.3% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | $-96.0K | ||
| Q3 25 | $-4.9M | $1.1M | ||
| Q2 25 | $-353.0K | $2.8M | ||
| Q1 25 | $1.2M | $3.0M | ||
| Q4 24 | $-16.7M | $1.7M | ||
| Q3 24 | $-4.7M | $-842.0K | ||
| Q2 24 | $1.4M | $-846.0K | ||
| Q1 24 | $-8.6M | $1.4M |
| Q4 25 | — | $-545.0K | ||
| Q3 25 | — | $877.0K | ||
| Q2 25 | — | $2.7M | ||
| Q1 25 | — | $2.5M | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | — | $-1.7M | ||
| Q1 24 | — | $758.0K |
| Q4 25 | — | -2.3% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | — | 13.0% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | -7.8% | ||
| Q2 24 | — | -7.2% | ||
| Q1 24 | — | 3.1% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | 95.83× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
HBIO
| Instruments Equipment Software And Accessories | $21.6M | 91% |
| Service Maintenance And Warranty Contracts | $2.1M | 9% |
